Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANG LIFESCIENCES INDIA ZYDUS LIFESCIENCES ANG LIFESCIENCES INDIA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 12.7 20.0 63.4% View Chart
P/BV x 1.9 2.4 80.5% View Chart
Dividend Yield % 0.8 0.6 129.1%  

Financials

 ANG LIFESCIENCES INDIA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ANG LIFESCIENCES INDIA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs800674 118.8%   
Low Rs87331 26.3%   
Sales per share (Unadj.) Rs341.7149.1 229.1%  
Earnings per share (Unadj.) Rs38.922.7 171.1%  
Cash flow per share (Unadj.) Rs44.529.7 150.0%  
Dividends per share (Unadj.) Rs1.002.50 40.0%  
Avg Dividend yield %0.20.5 45.3%  
Book value per share (Unadj.) Rs80.8166.1 48.6%  
Shares outstanding (eoy) m10.371,023.74 1.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.4 38.5%   
Avg P/E ratio x11.422.1 51.6%  
P/CF ratio (eoy) x10.016.9 58.9%  
Price / Book Value ratio x5.53.0 181.5%  
Dividend payout %2.611.0 23.4%   
Avg Mkt Cap Rs m4,600514,277 0.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21321,777 1.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,543152,652 2.3%  
Other income Rs m92,354 0.4%   
Total revenues Rs m3,552155,006 2.3%   
Gross profit Rs m67934,427 2.0%  
Depreciation Rs m597,130 0.8%   
Interest Rs m941,270 7.4%   
Profit before tax Rs m53528,381 1.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1325,117 2.6%   
Profit after tax Rs m40323,264 1.7%  
Gross profit margin %19.222.6 85.0%  
Effective tax rate %24.618.0 136.7%   
Net profit margin %11.415.2 74.7%  
BALANCE SHEET DATA
Current assets Rs m1,928122,614 1.6%   
Current liabilities Rs m1,66378,394 2.1%   
Net working cap to sales %7.529.0 25.8%  
Current ratio x1.21.6 74.1%  
Inventory Days Days193 1.5%  
Debtors Days Days1,05180 1,316.4%  
Net fixed assets Rs m939144,382 0.7%   
Share capital Rs m1041,024 10.1%   
"Free" reserves Rs m734168,972 0.4%   
Net worth Rs m838169,996 0.5%   
Long term debt Rs m2163,621 6.0%   
Total assets Rs m2,867266,996 1.1%  
Interest coverage x6.723.3 28.6%   
Debt to equity ratio x0.30 1,212.6%  
Sales to assets ratio x1.20.6 216.1%   
Return on assets %17.39.2 188.8%  
Return on equity %48.113.7 351.7%  
Return on capital %59.717.1 349.5%  
Exports to sales %00-   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA21,869 0.0%   
Fx inflow Rs m8663,065 0.1%   
Fx outflow Rs m6021,869 0.3%   
Net fx Rs m2741,196 0.1%   
CASH FLOW
From Operations Rs m24721,041 1.2%  
From Investments Rs m-44411,544 -3.8%  
From Financial Activity Rs m199-8,683 -2.3%  
Net Cashflow Rs m223,729 0.0%  

Share Holding

Indian Promoters % 71.2 75.0 94.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.5 -  
FIIs % 0.0 2.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.9 25.0 115.3%  
Shareholders   6,939 408,231 1.7%  
Pledged promoter(s) holding % 44.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANG LIFESCIENCES INDIA With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    PIRAMAL ENTERPRISES    


More on ANG LIFESCIENCES INDIA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ANG LIFESCIENCES INDIA vs Cadila Healthcare Share Price Performance

Period ANG LIFESCIENCES INDIA Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.04% -0.55% -0.05%
1-Month -14.59% -6.96% 0.08%
1-Year -76.33% -12.40% -7.13%
3-Year CAGR 39.86% 15.58% 20.04%
5-Year CAGR 9.82% -1.97% 11.01%

* Compound Annual Growth Rate

Here are more details on the ANG LIFESCIENCES INDIA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ANG LIFESCIENCES INDIA hold a 71.2% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ANG LIFESCIENCES INDIA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ANG LIFESCIENCES INDIA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 2.6%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of ANG LIFESCIENCES INDIA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 100 Points | Reliance, Asian Paints Top Gainers | Metal Stocks Bleed while Auto Stocks Rise(10:30 am)

Asian share markets are lower today as rare protests in major Chinese cities against the country's strict zero-Covid policy raised worries about management of the virus in the world's second-largest economy.